PART B REVENUE BOOSTER: CMS Allows Expanded Payment forj At-Home Prothombin Time Tests

Why This Topic Matters

Coverage changes for home INR testing can affect whether services are payable, how related education is captured, and how office-based monitoring encounters are billed and documented. Understanding the scope of the policy helps practices reduce claim denials and code anticoagulation management appropriately.

Article Sections

1. CMS coverage update for home INR monitoring

   Summarizes the Medicare policy change and the clinical situations addressed by the update. It also frames the article’s focus on payment and coverage for home testing services.

2. Patient education and home-testing service codes

   Discusses the general education and monitoring services associated with home INR testing. It references the Medicare coding framework used for these services.

3. In-office Coumadin clinic testing and office visit reporting

   Covers the distinction between home testing and in-office monitoring in physician practices. It also addresses general billing considerations for lab testing and low-level office visits when medically necessary.

4. Documentation example and claim support

   Provides a brief scenario illustrating how anticoagulation monitoring may be documented in a practice setting. The example is used to show the type of supporting information that may be relevant to billing.